Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40
Sex
Women only
Ages
Ages 50 Years to 54 Years
Primary completion
2025-11-20
Last update
2025-11-19

What this trial studies

Skeletal muscle mass plays an important role with both metabolism and functional capacity. It is well established that the aging process leads to a significant decline in both muscle mass and strength which is associated with frailty , an increased risk of falls and decreased physical fitness and function In this context, high-load resistance training has been shown to reduce the risk of falls and increase strength and functional capacity in middle-aged and/or elderly individuals. Aquatic exercise is one method that has previously been shown to improve muscle strength, balance, and coordination in those of advancing age Although the evidence supports the effectiveness of both water-based burpee exercise in middle-aged and elderly individuals, has, to our knowledge, never been investigated. Thus, the objective of this study was to assess the long-term effect of water-based burpee exercises

Conditions in scope

  • Burpee Exercise
  • Water Exercises
  • Functional Capacity
  • Postmenopausal
  • Thyroidectomy

Interventions

  • water based burpee exercises (Other) — water based burpee exercises ( Aquatic exercise ) is one method that has previously been shown to improve muscle strength, balance, and coordination in those of advancing age Although the evidence supports the effectiveness of both water-based burpee exercise in…
  • aerobic exercises (Other) — Traditional aerobic exercises for post-menopause include activities like brisk walking, jogging and cycling. These exercises help improve cardiovascular health, boost metabolism, and enhance mood. They can also be beneficial for maintaining bone density, especially weight-bearing exercises like walking and jogging.

Who can join

Women only · Ages 50 Years to 54 Years

Inclusion criteria

  • Adults aged 54 ± 4 years .
  • Post-menopausal women after tyhroidectomy
  • Body mass index (BMI) ≥ 30 kg/m².
  • Absence of osteoarticular dysfunctions in the lower limbs.
  • No personal history of cardiovascular disease
  • No water trauma
  • Non-smokers

Exclusion criteria

  • History of Cardiovascular disorders.
  • Severe osteoarticular dysfunctions.
  • Presence of Water panic.
  • Participation in another clinical trial within the last 30 days.
  • Neurologic and psychiatric disorders (spina bifida, cerebral palsy, anorexia nervosa, known autism spectrum disorders).

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

CityState / RegionFacilitySite status
Cairo Mohamed Saied Zidan Recruiting

Status & timeline

  • Overall status: Recruiting
  • Study type: Interventional
  • Phase: N/A
  • Start date: 2025-09-01
  • Primary completion: 2025-11-20
  • Last update posted: 2025-11-19
  • First posted: 2025-07-04

Lead sponsor: Al-Zaytoonah University of Jordan (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

  • FEV1/FVC ( % ) (pre and post 8 weeks)
    Description: The ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lungs. That can reflect pulmonary function , using portable spirometer ( SP 80B,China)
  • FEV1 ( liters ) (pre and post 8 weeks)
    Forced expiratory volume in 1 second that can reflect pulmonary function , using portable spirometer ( SP 80B,China)
  • PEF ( liters / minute ) (pre and post 8 weeks)
    Peak expiratory flow (PEF), a key indicator of lung function,using portable spirometer ( SP 80B,China)
  • FVC ( liters ) (Pre and post 8 weeks)
    Forced vital capacity (FVC) is the total amount of air exhaled during the FEV test. Forced expiratory volume and forced vital capacity are lung function tests , using portable spirometer ( SP 80B , China )
  • Chest expansion ( centimeter ) (Pre and post 8 weeks)
    A simple, noninvasive pulmonary function test used to assess chest wall mobility and, to a lesser extent, lung function , using tape measurement.

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.

Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT07052279 before contacting a site.

ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.